Of USD 200 million capex, USD 100 million will go into four key areas- Syngene Research Centre, biologic centre, formulation center, viral testing and the rest in commercial manufacturing, says Jonathan Hunt, CEO of Syngene International.
first published: Jul 22, 2016 01:13 pm
A collection of the most-viewed Moneycontrol videos.

Live: Nifty snaps 4-day winning streak but rises 1% this week | Closing Bell

Live: Can Bihar poll outcome trigger Nifty to reclaim 26,000-mark? | Opening Bell

Live: Nifty holds above 25,900 but off nearly 100 pts from day's high | Closing Bell

Live: Will Nifty reclaim 26,000-mark amid record low inflation in Oct? | Opening Bell
You are already a Moneycontrol Pro user.

